This month the 33rd Annual Meeting of the European Society for Hyperthermic Oncology (ESHO 2019) will be held in Warsaw, Poland, at the Warsaw Plaza Hotel, on May 22 - 24, 2019. The conference invites thermal oncology professionals with extensive clinical and scientific experience to share their expertise in the field.
Pyrexar Represented by:
The conference includes over 58 presentations by leading hyperthermia experts. Highlights below:
|MR thermometry validation and modeling of a 915 MHz annular phased-array in brain phantoms||Paul Turner|
|A meta-analysis of clinical trials with hyperthermia||Niloy Datta|
|Protons and hyperthermia: early clinical results||Zeljko Vujaskovic|
|Building an international forum to boost hyperthermic research||Stephan Bodis|
|Quality assurance guidelines for hyperthermia||H. Dobsicek Trefna|
|Quality assurance assessment: are commercial MR-guided deep-pelvic hyperthermia devices ready for a large clinical trial?||Sergio Curto|
|QA techniques for radiative deep hyperthermia systems: benefits and limitations of 1D, 2D, and 3D techniques||Gerard van Rhoon|
|Combined interstitial radiotherapy with interstitial hyperthermia||Andrzej Kukielka|
|Thermochemoradiotherapy for locally advanced pancreatic cancers: A pilot study||Niloy Datta|
|Radiotherapy in combination with regional Hyperthermia for Salvage Treatment in refractory Childhood Cancer||Rudiger Wessalowski|
|Full program available here.|
A special thanks to the 2019 ESHO committee for organizing this year's event and to the Maria Sklodowska-Curie Institute — Oncology Center for hosting the hyperthermia workshops.